- Home
- CNF vs IINN Comparison
CNF vs IINN Comparison
Compare CNF & IINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNF
- IINN
- Stock Information
- Founded
- CNF 1999
- IINN 2018
- Country
- CNF China
- IINN Israel
- Employees
- CNF N/A
- IINN N/A
- Industry
- CNF Finance: Consumer Services
- IINN Medical/Dental Instruments
- Sector
- CNF Finance
- IINN Health Care
- Exchange
- CNF Nasdaq
- IINN Nasdaq
- Market Cap
- CNF 35.7M
- IINN 34.1M
- IPO Year
- CNF 2018
- IINN 2021
- Fundamental
- Price
- CNF $0.41
- IINN $1.15
- Analyst Decision
- CNF
- IINN Strong Buy
- Analyst Count
- CNF 0
- IINN 1
- Target Price
- CNF N/A
- IINN $2.00
- AVG Volume (30 Days)
- CNF 144.8K
- IINN 1.5M
- Earning Date
- CNF 08-28-2025
- IINN 09-09-2025
- Dividend Yield
- CNF N/A
- IINN N/A
- EPS Growth
- CNF N/A
- IINN N/A
- EPS
- CNF N/A
- IINN N/A
- Revenue
- CNF $50,241,013.00
- IINN N/A
- Revenue This Year
- CNF $252.34
- IINN N/A
- Revenue Next Year
- CNF N/A
- IINN $2,050.00
- P/E Ratio
- CNF N/A
- IINN N/A
- Revenue Growth
- CNF N/A
- IINN N/A
- 52 Week Low
- CNF $0.37
- IINN $0.40
- 52 Week High
- CNF $2.84
- IINN $1.65
- Technical
- Relative Strength Index (RSI)
- CNF 30.28
- IINN 44.81
- Support Level
- CNF $0.46
- IINN $1.11
- Resistance Level
- CNF $0.55
- IINN $1.19
- Average True Range (ATR)
- CNF 0.07
- IINN 0.12
- MACD
- CNF -0.02
- IINN -0.02
- Stochastic Oscillator
- CNF 12.86
- IINN 14.63
About CNF CNFinance Holdings Limited each representing twenty (20)
CNFinance Holdings Ltd is an equity loan service provider. It focuses on the development of small and micro-enterprises. It generates revenue in the form of interest and financing service fees on loans and interest on deposits with banks. Its primary target borrower segment is MSE owners who own real properties in Tier 1 and Tier 2 cities in China. Geographically, it has an operation in PRC.
About IINN Inspira Technologies Oxy B.H.N. Ltd.
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. The respiratory care devices market is segmented geographically into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.